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ABSTRACT Amplicon sequencing of the 16S rRNA gene is commonly used for the
identification of bacterial isolates in diagnostic laboratories and mostly relies on the
Sanger sequencing method. The latter, however, suffers from a number of limita-
tions, with the most significant being the inability to resolve mixed amplicons when
closely related species are coamplified from a mixed culture. This often leads to ei-
ther increased turnaround time or absence of usable sequence data. Short-read
next-generation sequencing (NGS) technologies could solve the mixed amplicon is-
sue but would lack both cost efficiency at low throughput and fast turnaround
times. Nanopore sequencing developed by Oxford Nanopore Technologies (ONT)
could solve those issues by enabling a flexible number of samples per run and an
adjustable sequencing time. Here, we report on the development of a standardized
laboratory workflow combined with a fully automated analysis pipeline LORCAN
(long read consensus analysis), which together provide a sample-to-report solution
for amplicon sequencing and taxonomic identification of the resulting consensus se-
quences. Validation of the approach was conducted on a panel of reference strains
and on clinical samples consisting of single or mixed rRNA amplicons associated
with various bacterial genera by direct comparison to the corresponding Sanger se-
quences. Additionally, simulated read and amplicon mixtures were used to assess
LORCAN’s behavior when dealing with samples with known cross-contamination
levels. We demonstrate that by combining ONT amplicon sequencing results with
LORCAN, the accuracy of Sanger sequencing can be closely matched (99.6% se-
quence identity) and that mixed samples can be resolved at the single-base resolu-
tion level. The presented approach has the potential to significantly improve the
flexibility, reliability, and availability of amplicon sequencing in diagnostic settings.
KEYWORDS taxonomy, 16S RNA gene, bioinformatics, clinical methods, diagnostics,
nanopore, sequencing
The sequencing of the 16S rRNA gene is essential to describe the diversity of thehuman microbiome (1, 2). Yet, the frequency of the use of 16S sequencing for
species identification from cultured isolates in clinical laboratories is decreasing (3)
despite the usefulness of 16S rRNA gene sequencing to provide taxonomic classifica-
tion for isolates that do not match recognized biochemical profiles, that only produce
low identification score according to commercial systems, or that are not typically
associated with human pathogens (3, 4). In the clinical microbiology laboratory, am-
plicon sequencing of the 16S rRNA gene mostly relies on the Sanger sequencing
method, which is based on chain termination via fluorescently labeled deoxyribonucle-
otides (dNTPs), capillary electrophoresis, and fluorescence measurement (5). Although
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the Sanger method is still the gold standard for validating the accuracy of sequences
from specific genes, when compared to more recent technologies, the method has a
number of significant shortcomings. During a sequencing run, each capillary is limited
to the production of one single sequence with a maximal length of about 1,000 bp (6),
resulting in low throughput and high sequencing costs. Furthermore, the sequencing
machines are comparably large and require maintenance, limiting their suitability for all
types of laboratory settings. The most important limitation of the Sanger method,
however, is its limited ability to produce complete sequence information when diverse
amplicons are present (7). Under routine diagnostic conditions, this frequently leads to
either increased turnaround time or lack of results (8), leading to potential delays or
inaccuracies in patient treatment and management.
Next-generation sequencing technologies (i.e., second-generation sequencing tech-
nologies, such as those provided by Illumina) might overcome most of these limitations
but are not designed for the analysis of small numbers of pure amplicons. Even the
smallest and fastest available 500- and 600-cycle Illumina kits show runtimes of 24 h,
with associated running costs of several hundred euro regardless of the numbers of
samples processed (Illumina, Inc.), limiting their usefulness for the fast and flexible
identification of small batches of samples. The third-generation single-molecule se-
quencing technology provided by Oxford Nanopore Technologies (ONT) might offer
the necessary flexibility in throughput and is capable of producing reads with lengths
of several hundred to several hundred thousand bases at competitive costs (9).
Furthermore, ONT sequencers are small devices, virtually maintenance free, and afford-
able for small laboratories. Despite the constant improvement over the last years in
read accuracy (with read accuracy of about 96% currently), the remaining sequencing
errors in single nanopore reads do not yet allow for an analysis at the read level. De
novo assembly or consensus generation from individual ONT reads are, therefore,
commonly used to generate sequences that are virtually free from substitution errors
(10). Additionally, “polishing” tools can be applied to remove remaining nonrandom
errors, such as indels in homopolymer regions, from the generated consensus se-
quences (10–13). Resulting sequences can then be directly substituted to Sanger
sequences in existing classification pipelines or, due to the added flexibility in read
length, may provide far higher resolution if the analyses are based on full-length marker
genes or entire operons (14). One obstacle for a broad adoption of nanopore sequenc-
ing in routine diagnostic laboratories is the added bioinformatic complexity compared
to established Sanger sequencing workflows. Furthermore, available workflows are
often limited to the analysis of pure amplicons (10–13), include complex modifications
of the ONT laboratory workflows (15, 16), or lack published validation by using samples
other than mock communities (17, 18).
Here, we developed a complete workflow based on standard ONT protocols and a
fully automated analysis pipeline LORCAN capable of producing high-quality consensus
sequences and thorough taxonomic analysis from pure and low-complexity cultures.
The foreseen end users of the workflow are clinical bacteriology laboratories. As such,
tunable workflow parameters were evaluated with amplicons generated from reference
strains of pathogenic genera (Bacteroides, Eggerthella, Enterococcus, Klebsiella, Mycobac-
terium, Campylobacter, Pseudomonas) and validated on bacterial cultures obtained from
patient material over several months. Furthermore, we explored the robustness of
LORCAN’s consensus generation and species identification by analyzing artificial mix-
tures of amplicons and reads at different levels of genetic distances.
MATERIALS AND METHODS
Samples, DNA extraction, PCR amplification. Bacterial isolates all originated from the Institute for
Infectious Diseases (IFIK, Bern) Biobank. The IFIK provides the entire spectrum of medical microbiological
diagnostic services to the largest Swiss hospital group (Inselgruppe) and other regional hospitals.
The diagnostic division of IFIK (clinical microbiology) is ISO/IEC 17025 accredited to perform routine
bacterial diagnostics from clinical samples. ATCC strains were obtained from LGC Standards (Wesel,
Germany) and were grown on solid medium as recommended by the manufacturer.
Bacterial cultures grown overnight were harvested from agar plates and dissolved in 300 l of
Tris-EDTA (pH 8.0). DNA was extracted with a NucliSens easyMag (bioMérieux, Switzerland) robot
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according to the manufacturer’s protocol. The 16S rRNA gene PCR was performed with the primer sets
16S_f, 5=-AGAGTTTGATCMTGGCTCAG-3=, and 16S_r, 5=-TACCGCGGCWGCTGGCACRDA-3=, (general bac-
teria) and mbak_f, 5=-GAGTTTGATCCTGGCTCAGGA-3=, and mbak_r, 5=-TGCACACAGGCCACAAGGGA-3=,
(mycobacteria) supplemented with the universal tails 5=-TTTCTGTTGGTGCTGATATTGC-3= (ONT forward
primer), 5=-ACTTGCCTGTCGCTCTATCTTC-3= (ONT reverse primer), 5=-TGTAAAACGACGGCCAG-3= (M13f,
Sanger forward primer), or 5=-CAGGAAACAGCTATGAC-3= (M13r, Sanger reverse primer). PCR mixtures
(25 l) for general bacteria and mycobacteria were assembled, respectively, with 1 and 2.5 ng DNA
template and 10 l of a 1.25 and 2.5 M primer working solution, both with 12.5 l Q5 master mix.
Amplification was performed in a GeneAmp 9700 thermocycler (Thermo Fisher Scientific, Inc., MA, USA)
with the following program: 98°C for 1 min; 30 cycles of 98°C for 10 s, 63°C for 15 s, 72°C for 30 s; and
72°C for 2 min. PCR products were purified with CleanNGS beads (CleanNA, Waddinxveen, Netherlands)
according to the manufacturer’s instructions with the following modifications: after the washing step, an
additional 3-s centrifugation step was introduced, and the purified DNA was eluted in 80 l of Tris-HCl
(0.01 M, pH 8.0). Fragment size of the amplicons was analyzed using the TapeStation D1000 assay
(Agilent, Santa Clara, CA, USA), concentrations were measured with the Qubit double-stranded DNA
(dsDNA) broad-range (BR) assay (Thermo Fisher Scientific), and the purity of the DNA was analyzed with
a NanoDrop spectrophotometer (Thermo Fisher Scientific). Samples with DNA concentrations of
1.05 nM were excluded from the analysis.
Library preparation. A typical library consisted of the pooling of PCR amplicons from 2 to 15
clinical samples and 1 positive control (Mycobacteria intracellulare, amplified with general bacterial
primers). Library preparation was performed with the kits EXP-PBC096 and SQL-LSK109 (Oxford
Nanopore Technologies, Oxford, UK) using the supplementary reagents NEBNext end repair/dA-
tailing module (E7546; New England Biolabs, ON, CA), NEB Blunt/TA ligase master mix (M0367; New
England Biolabs), Taq 2 master mix (NEB M0270; New England Biolabs), and CleanNGS beads
(CleanNA). All modifications made to the manufacturer’s protocol (PCR barcoding [96] genomic DNA,
PBAC96_9069_v109_revK_14Aug2019) are described in the following section (see also Fig. 1A; for a
detailed protocol, see Text S1 in the supplemental material). AMPure beads were substituted with
CleanNGS beads, and the HulaMixer (Thermo Fisher Scientific) parameters “orbital: 40 rpm, 07 s; recip-
rocal: 89 deg, 2 s; vibro: 5 deg, 2 s; vertical position” were used. Barcoding PCRs (12 cycles) were set up
with 25.2 nmol of template per reaction. Raw barcoded PCR products were quantified with the Qubit
dsDNA BR assay and pooled at equal molar proportions. Products containing less than 0.57 pmol DNA
were excluded from the analysis. If the total amount of DNA in a pooled library was below 9.23 pmol,
“place-holder” (filling) barcoded samples were added to the pooled library to avoid flow cell underload-
ing (see example of calculations and adjustments in Text S1). Place-holder barcoded samples were
produced in advance from the same template as the positive controls, with 15 instead of 12 barcoding
PCR cycles. Resulting PCR products were quantified with Qubit and stored at 20°C. The pooled library
was purified (CleanNGS beads; 50-l elution volume) and quantified with the Qubit dsDNA BR assay. The
purified library pools were diluted to 140 nM before proceeding to the “end preparation” step of the
protocol.
Sequencing. ONT sequencing was performed on a GridION X5 instrument (Oxford Nanopore
Technologies) with real-time basecalling enabled (ont-guppy-for-gridion v.1.4.3-1 and v.3.0.3-1; fast
basecalling mode). Sequencing runs were terminated after production of 1 million reads or when
sequencing rates dropped below 20 reads per second. Purified PCR products were submitted to Sanger
sequencing at Microsynth (Balgach, Switzerland).
Bioinformatic analyses. (i) LORCAN pipeline description. LORCAN was developed to facilitate
reproducible ONT sequencing-based marker gene analysis in diagnostics facilities. The pipeline, written
in Perl 5, R, and BASH, runs on Linux servers or workstations. The code is publicly available (19) and is
based on publicly available, third-party dependencies (see Table S1 in the supplemental material). Major
steps of the workflow are described in the following section (numbers correspond to the steps in Fig. 1B).
In step 1, basecalled reads are demultiplexed and adapters trimmed (Porechop [20], parameters: –format
fasta, –discard_unassigned, –require_two_barcodes). In step 2, reads are filtered by length, keeping only
those with lengths of 20 to 100 bases (lower boundary adjustable) around the modal sequence
length (custom Perl and R scripts) (Fig. 1B). In step 3, reads are mapped to a nonredundant reference
database (minimap2 [21]; see database preparation below). In step 4, reads are extracted, binned by
taxonomic level (here species), and remapped to the reference sequence that obtained the highest
number of mapped reads among all sequences of the corresponding species (minimap2, SAMtools [22],
SeqKit [23]). In step 5, consensus sequences are derived using a 50% majority rule consensus. In step 6,
the 10 closest reference sequences are selected by sequence similarity to the consensus sequence
(blastn, BLAST [24]). In step 7, phylogenetic trees for each consensus sequence with its 10 closest
references are created (MAFFT [25] with parameters -maxiterate 1000 –localpair; gBlocks [26] with
parameters t d; and IQ-Tree [27] with parameters -m GTRIG -bb 1000 -czb). Parameters of all
software are also provided in the LORCAN GitHub repository.
(ii) Database preparation. Reference databases used by LORCAN are nonredundant and assay
specific. Detailed instructions for database creation are provided online (https://github.com/aramette/
LORCAN/). In short, the reference database (in this study, leBIBI SSU-rDNA-mk37_stringent, https://
umr5558-bibiserv.univ-lyon1.fr/BIBIDOCNEW/db-BIBI.html [28]) was trimmed to the region of interest
(amplified region minus primers) and dereplicated (mothur [29]), and sequence names were simplified
(custom Perl scripts). The names of identical sequences are saved to a file during the dereplication step.
The resulting nonredundant database is then used to generate a custom BLAST database, which is used
in LORCAN pipeline.
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(iii) Sanger sequence analyses. Forward and reverse sequences were assembled into consensus
sequences using SeqMan Pro (DNA Star, Madison, WI, USA), primers were trimmed manually, and
ambiguous bases were resolved based on visual inspection of the chromatograms. Consensus sequences
were taxonomically classified using the online tool leBIBI QBPP (28, 30).
(iv) SNV discrimination and performance with mixed samples. Amplicons produced from pure
samples were quantified (Qubit dsDNA BR assay). Mixtures of pure amplicons were produced at defined
ratios before library preparation to produce libraries of heterogeneous (“mixed”) samples. Artificial read
mixtures were also produced in silico by mixing reads originating from pure amplicon samples. Those
reads were obtained from the LORCAN output directories (output file 1_fasta/BC*.fasta produced by
FIG 1 (A) Overview of the wet laboratory workflow. Steps of the LORCAN analysis (B) and corresponding sections of the generated report (C). (Step 1)
Demultiplexing and adapter trimming. (Step 2) Read filtering by size. (Step 3) Mapping to a reference database. (Step 4) Read extraction, binning by species,
and remapping. (Step 5) Consensus calling. (Step 6) Selection of the closest references by BLAST. (Step 7) Taxonomic tree building.
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step 2) (Fig. 1B) and sampled using Seqtk subseq (v.1.3-r106) (https://github.com/lh3/seqtk) to produce
different proportions of original, pure amplicons. Reads from mixed amplicon samples were fed back into
LORCAN, and detected species compositions were extracted from the resulting LORCAN reports. Se-
quence identities between the paired Mycobacterium species were determined based on pairwise
alignment of the amplified region using MultAlin v.5.4.1 (http://multalin.toulouse.inra.fr/multalin/ [31]).
(v) Influence of database completeness on consensus accuracy. Amplicons from a set of seven
ATCC reference strains were ONT sequenced and analyzed with LORCAN using the full nonredundant
leBIBI 16S rRNA database, restricted to the region amplified by the general bacterial primer set. The
resulting top consensus sequences were extracted and combined with the above-mentioned database.
The resulting sequence data set was aligned (MAFFT v.7.313, FFT-NS-1, progressive method), and
pairwise distances were calculated (mothur v.1.40.5, dist.seqs, calc  eachgap, countends  F, cut-
off 0.20). For each consensus sequence, 10 subsets of sequences with minimal distances below
thresholds ranging from 0 to 0.1 were extracted (Seqtk subseq), and minimal distances between each
data set and the corresponding consensus sequence were analyzed. The seven ATCC read sets were
reanalyzed with LORCAN and the corresponding database subsets to produce consensus sequences. Top
consensus sequences from each combination of sample and subsetted database were extracted,
combined with the consensus sequences generated with the full database, and aligned (MAFFT v.7.313,
L-INS-I, iterative refinement method (16) with local pairwise alignment information). Pairwise distances
were analyzed as described above, and distances between the consensus sequences generated with the
full and the subsetted databases were extracted.
Data availability. All reads and consensus sequences corresponding to the data presented in Table
1 and the LORCAN-derived consensus sequences used as references in Fig. 3 were deposited in the
European Nucleotide Archive under project accession number PRJEB34167 or made available as sup-
plementary multi-FASTA files.
TABLE 1 Validation of taxonomic classification of ATCC reference strainsa
ATCC strain
reference no. Taxonomy
LORCAN top consensus sequence
SANGER consensus sequence
leBIBI QBPP taxonomyb
LORCAN vs Sanger
consensus sequence
identity (%)LORCAN taxonomy leBIBI QBPP taxonomyb
33560 Campylobacter jejuni
subsp. jejuni
Campylobacter jejuni [Campylobacter lari subsp.
concheus, Campylobacter jejuni
subsp. jejuni*, Campylobacter
jejuni subsp. doylei] (and 2
others)
[Campylobacter lari subsp.
concheus, Campylobacter jejuni
subsp. jejuni*, Campylobacter
jejuni subsp. doylei] (and 2
others)
99.77
43504 Helicobacter pylori Helicobacter pylori [Helicobacter pylori*] [Helicobacter pylori*] 99.54
29212 Enterococcus faecalis Enterococcus faecalis [Enterococcus faecalis*] [Enterococcus faecalis*] 100.00
25922 Escherichia coli Escherichia coli [Escherichia marmotae,
Escherichia fergusonii] Shigella
flexneri*
[Shigella flexneri] 99.57
49247 Haemophilus
influenzae
Haemophilus
influenzae
[Haemophilus influenzae*] [Haemophilus influenzae*] 98.94
49226 Neisseria
gonorrhoeae
Neisseria
gonorrhoeae
[Neisseria gonorrhoeae*] [Neisseria gonorrhoeae*] 100.00
27853 Pseudomonas
aeruginosa
Pseudomonas
aeruginosa
[Pseudomonas tropicalis*,
Pseudomonas aeruginosa,
Pseudomonas hussainii]
[Pseudomonas tropicalis*,
Pseudomonas indica,
Pseudomonas aeruginosa]
99.78
25923 Staphylococcus
aureus
Staphylococcus
aureus
[Staphylococcus aureus subsp.
anaerobius*]
[Staphylococcus argenteus,
Staphylococcus aureus subsp.
aureus, Staphylococcus
schweitzeri*] (and 2 others)
99.79
49619 Streptococcus
pneumoniae
Streptococcus
pneumoniae
[Streptococcus pneumoniae*,
Streptococcus
pseudopneumoniae]
[Streptococcus mitis,
Streptococcus pneumoniae*]
99.79
29741 Bacteroides
thetaiotaomicron
Bacteroides
thetaiotaomicron
[Bacteroides thetaiotaomicron*] [Bacteroides thetaiotaomicron*] 99.78
43055 Eggerthella lenta Eggerthella lenta [Eggerthella lenta*] [Eggerthella lenta*, Eggerthella
timonensis]
99.32
51299 Enterococcus faecalis Enterococcus faecalis [Enterococcus faecalis*] [Enterococcus faecalis*] 100.00
8176 Moraxella catarrhalis Moraxella catarrhalis [Moraxella canis, Moraxella
catarrhalis*, Moraxella
nonliquefaciens]
[Moraxella canis, Moraxella
catarrhalis*]
100.00
BAA-1705 Klebsiella
pneumoniae
Klebsiella
pneumoniae
[Klebsiella variicola, Klebsiella
quasivariicola*]
[Klebsiella pneumoniae subsp.
rhinoscleromatis*, Klebsiella
quasipneumoniae subsp.
quasipneumoniae]
98.93
13637 Stenotrophomonas
maltophilia
Stenotrophomonas
maltophilia
[Stenotrophomonas maltophilia*] [Stenotrophomonas maltophilia] 100.00
aSamples were analyzed in parallel by Sanger sequencing and with the LORCAN approach. The resulting consensus sequences were submitted to the online
taxonomic identification platform leBIBI QBPP.
bSquare brackets indicate proximal clusters. Asterisks indicate closest sequences based on patristic distances.
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RESULTS
We present a standardized laboratory workflow accompanied by a fully automated
analysis pipeline, which together provide a sample-to-report solution for taxonomic
identification of bacterial cultures based on amplicon sequencing of their 16S rRNA
genes (Fig. 1). The laboratory workflow, which was tested and adjusted for parallel
processing of up to 16 samples done manually by a single person (theoretically scalable
up to 96 samples using automation), includes stringent quality control steps to guar-
antee consistent results. The whole procedure has been running under ISO/IEC 17025
accreditation standards since January 2019 in our microbial diagnostic department. The
analysis pipeline is based on publicly available software components and runs on Linux
servers or workstations. It automates quality control, demultiplexing, consensus se-
quence generation, taxonomic analysis based on the highly curated leBIBI 16S data-
base, as well as report generation (text, PDF; see example report in the supplemental
material). Turnaround time from raw amplicons to PDF reporting is about 8 h (consist-
ing of 6 h wet lab, 1 h sequencing, and 1 h bioinformatic analysis). Validation of the
sequencing results was conducted by direct comparison to Sanger sequencing with
real clinical samples consisting of pure or mixed rRNA amplicons belonging to several
bacterial genera (Bacteroides, Eggerthella, Enterococcus, Klebsiella, Mycobacterium, Cam-
pylobacter, Pseudomonas) of expected amplicon sizes of 500 bp (longer amplicons of ca.
900 bp were also successfully analyzed with the proposed pipeline; data not shown).
Additionally, we created artificial amplicon and read mixtures from different bacterial
species to assess the workflow’s performance and robustness when confronted with
contaminated samples. We demonstrated that by combining ONT sequencing and
LORCAN, the accuracy of Sanger sequencing can be closely matched (99.6% sequence
identity on average) and that mixed samples can be resolved at the single-base
resolution level.
Validation of SNV discrimination and analysis of mixed samples. To test the
ability of LORCAN to resolve mixed samples, artificial mixtures were created by mixing
either amplicons (Fig. 2A) or reads produced from pure samples (Fig. 2B and C; see also
Fig. S1 and S2 in the supplemental material). The taxonomic identity of all involved
strains was successfully recovered by LORCAN. The slightly lower amplicon length of
Pseudomonas aeruginosa compared to those of Staphylococcus aureus and Enterococcus
faecalis resulted in a slight underrepresentation of the latter in the mixtures (Fig. 2B)
due to the narrow size window chosen for read size selection (the lower boundary of
the size window around the modal read length is adjustable in the LORCAN command
line). The mixture of two Mycobacterium species (97.6% sequence identity in the
amplified region) (Fig. 2C) was accurately reproduced.
Influence of database completeness on consensus accuracy and taxonomic
classification. We analyzed the influence of reference database completeness on the
resulting consensus quality and accuracy by creating incomplete reference databases,
from which we excluded reference sequences if they were too close to the ideal
reference sequence, and then performed LORCAN analysis with each of these truncated
databases in turn. The genetic distances of the closest reference sequences in the
reference database strongly influenced the accuracy of the resulting consensus se-
quences. For instance, Enterococcus faecalis showed the lowest consensus accuracy at
95% database identity (Fig. 3). This was caused by gaps in the closest reference
sequence available. For databases with closest identities of 94%, the reference
sequence with the identified gaps was absent and consensus quality increased again
(see Fig. S3 and S4 in the supplemental material). Classification at the species level was,
however, virtually unaffected in pure amplicons. The Eggerthella lenta data set con-
tained a contamination of Pseudomonas stutzeri reads (0.8% of all reads), which did not
influence classification when reference sequences that enabled the mapping of Egg-
erthella lenta reads were available. In the absence of sufficiently close reference
sequences, the sample was misidentified (Fig. 3A). Information provided in the LORCAN
report did, however, reveal that the Pseudomonas stutzeri consensus sequence was only
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based on 20 out of 850 reads, which therefore indicated a likely case of suboptimal
taxonomic classification.
Validation of sequence consensuses generated by the combination of nano-
pore sequencing and LORCAN. The comparison of 78 LORCAN-generated consensus
sequences from 14 sequencing runs (including 49 clinical samples and 15 ATCC
reference strains) to their corresponding Sanger sequences revealed an average se-
quence identity of 99.6%  0.6 (standard deviation). The positive control (originating
from the same pool of amplicons) that was systematically sequenced in these 14 runs
showed an average identity of 99.8%  0.2 to its corresponding Sanger sequence. All
reference strains were correctly identified at the species level by LORCAN. Identification
by leBIBI QBPP resulted in assignment of the expected species (lowest patristic dis-
tance) or the placement of the expected species in the proximal cluster of the query
sequence (in the phylogenetic tree) in all but two cases. In these cases, the analyzed
strains were placed in close neighborhood of the expected species in the phylogenetic
tree produced by leBIBI QBPP (Table 1; see also Fig. S5 in the supplemental material).
Comparison of sequencing costs. Costs per sample of the Sanger method were the
lowest across different sequencing technologies (Fig. 4), provided the analyzed ampli-
cons are pure and short enough to be covered by a single sequence at sufficient
quality. Among the analyzed next-generation sequencing (NGS) methods, nanopore
sequencing was by far the most cost-effective option particularly at throughputs of 24
to 48 samples. The high costs per sample for Illumina are mainly caused by the
FIG 2 Taxonomic analysis of amplicon mixtures by LORCAN. Amplicons from Staphylococcus aureus, Enterococcus faecalis, and Pseudomo-
nas aeruginosa mixed after PCR amplification (A) and mixed in silico from reads obtained from pure amplicons (B). Standard deviations
indicate the variability across three independent replicate samples. None of the observed ratios was significantly different from the
expected ratios (chi-square test for expected probabilities; P 0.99). (C) In silico mixtures of Mycobacterium gordonae and Mycobacterium
avium.
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nonreusable sequencing cartridges (the full costs apply regardless of the number of
processed samples) and the comparably high prices of the library preparation kits.
Effects of parameter modifications on LORCAN results. We studied the influence
of the read size fraction (relative to the modal read length) and the number of input
reads on LORCAN consensus quality. In short, optimal results were obtained when reads
shorter than 20 bases below the modal read length were excluded from the analysis
(see Fig. S6 in the supplemental material). Further, we found 100 reads to be sufficient
for the generation of high-quality consensus sequences (see Fig. S7, S8, and S9 in the
supplemental material). The required number of input reads may vary with the taxo-
nomic complexity of the analyzed samples and the resolution required by the operator.
From a theoretical viewpoint (Fig. 1B, step 2), a total of 3,000 size-selected reads may
allow for the creation of high-quality consensus sequences and reliable species iden-
tification for species contributing 3.3% of those 3,000 selected reads (i.e., when
setting a minimum reference mapping depth of 100 reads in LORCAN, which corre-
sponds to the minimum number of reads recommended for reliable consensus creation
[see Fig. S7]). In most cases, however, even when a sample may consist of amplicons
derived from a unique species, not all reads are assigned to the target species (e.g., due
FIG 3 Influence of reference database completeness on consensus sequence accuracy. Each consensus sequence was compared
to a consensus sequence produced with a perfectly matching reference sequence. Additionally, each consensus sequence was
identified by BLAST similarity search against the full reference database. The uneven spacing of the data points reflects the
database composition after subsetting. Missing values are a result of insufficient numbers of reads mapping to the reference
database. (A) Filled circles indicate correct taxonomic identification of the ATCC strains. The low identities and unsuccessful
identification of Eggerthella lenta are a result of a low-level contamination in combination with unsuccessful mapping of the
Eggerthella reads. (B) The diameter of the circles is proportional to the number of reads mapped and further used in the consensus
generation step (obtained from the LORCAN output). Additional detail is provided in Table S3 and Fig. S10 in the supplemental
material.
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to read errors and/or the presence of highly similar sequences associated with other
species in the reference database). Furthermore, demultiplexing and size selection
could result in significant reduction of available reads. For illustrative purposes, during
our last 11 sequencing runs consisting of 89 samples (including place-holder samples;
see Library preparation in Materials and Methods), an average of 639,944 267,704
basecalled reads were produced, while multiplexing on average 8 3 barcoded sam-
ples per sequencing run. Read demultiplexing produced thereafter an average of
46,571 22,129 reads per library (i.e., in 58% of all reads, both index sequences have
been identified and assigned to the same barcode). This comparably high read loss
resulted from the stringent demultiplexing parameters used (detection of both 5= and
3= barcodes required, exclusion of reads with internal barcodes), which may effec-
tively prevent cross talk between libraries (32). Subsequent size selection (read
length of 20 to 100 bp around the modal sequence length) resulted in an
average of 43,265 21,305 reads per barcode, which were available for further pro-
cessing. Samples producing more than 3,000 reads of the expected amplicon size were
further down-sampled (adjustable LORCAN parameter), resulting in an average number
of used reads of 3,008 6 reads per sample. All samples, controls, and place holders
processed in these 11 sequencing runs were successfully taxonomically identified.
Although species identification could have been achieved with a lower number of reads
per sample, sequence production was fast (i.e., approximately 1 to 2 h for 1 million
reads), and even if flow cells may have been reused up to four times, the maximal
sequencing capacity of the flow cells was never utilized (see Table S2 in the supple-
mental material).
DISCUSSION
We present here the first sample-to-report solution for marker-gene-based taxo-
nomic identification of bacterial cultures specifically designed for clinical applications.
We extensively tested the influences of various analysis parameters and, therefore,
provide a basis for optimal tuning of the LORCAN pipeline to specific requirements. We
demonstrated that reads significantly shorter than the modal read length showed
reduced mapability to reference sequences and that resulting consensus sequences
were of reduced quality. No such observations were made when using reads from
longer-length fractions (see Fig. S6 in the supplemental material). Therefore, we ex-
cluded reads that were significantly shorter than the mode of the read length distri-
bution (by 20 bases) from the analysis with the corresponding command line parameter
in LORCAN. With these parameters being set this way, accurate consensus sequences
FIG 4 Cost estimate based on current list prices in Switzerland (currency CHF, December 2019). Prices for Illumina
and Nanopore sequencing include reagents and consumables; prices for Sanger sequencing correspond to the
rates at a large local service provider. The lines of MiniSeq and MiSeq v3 are confounded in the figure. Detail is
provided in Table S4 in the supplemental material.
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(99% identity to Sanger sequences produced from the same DNA) were reliably
produced with as few as 100 size-filtered reads per sample (see Fig. S7 in the supple-
mental material), confirming previous findings (33).
Applicability to samples consisting of mixed amplicons was a key requirement
during development of LORCAN, as contaminations are not rare in bacterial cultures
derived from clinical samples. To exclude sources of variation due to fluctuations in wet
laboratory processes, we analyzed artificially mixed amplicons based on pure reads
generated from pure amplicons. LORCAN showed high robustness against such mixture
events and was capable of quantitatively representing read compositions in mixed
samples as long as the analyzed gene region and the used database provide the
required taxonomic resolution. Nevertheless, we consider our approach as semiquan-
titative, as biases inherent to DNA extraction and amplicon generation might occur. In
addition, the presence of near-identical reference sequences belonging to different
species can result in elevated levels of background due to misassignment of a fraction
of the reads. Although we could observe a likely bias due to this phenomenon (see Fig.
S1 in the supplemental material), the bias did not prevent the correct taxonomic
identification of the most abundant species in any of our experiments. Furthermore,
this bias can be mitigated by choosing longer amplicons, and the planned improve-
ment in read quality by ONT will likely improve discrimination under such conditions.
A number of studies on ONT-based marker gene analysis have been published over
the past years, covering a range of different laboratory and computational approaches
aiming to obtain high-quality sequences from ONT reads. Most computational work-
flows either include reference-based consensus generation or de novo assembly in
combination with additional error correction steps. They were reported to perform
similarly in terms of the accuracy of the produced sequences (12, 13, 15, 17, 33). De
novo approaches are preferable when reference sequences are missing; however, so far,
the only studies demonstrating “reference-free” consensus generation from complex
samples (e.g., mock communities) relied on rather laborious wet lab procedures, such
as rolling cycle amplification or unique tagging of the individual amplicons before
sequencing (15, 16). Unlike previous studies, we specifically designed our workflow for
clinical routine applications. Compatibility with mixed samples and time/cost efficacy
were therefore key requirements, and comprehensive reference databases were readily
available. We therefore chose a reference-based approach allowing us to separate reads
originating from mixed cultures while using standard ONT protocols. Furthermore, and
in contrast to most previous studies, we omitted consensus error correction, which is
commonly applied to remove homopolymer errors from consensus sequences and
assemblies produced from nanopore reads (12, 13), because we did not detect a
negative influence of the latter errors in our taxonomic classification approach.
The strengths of our approach are that overall the procedure is faster, more flexible,
and more cost-effective than Sanger or Illumina-based approaches, as it relies on both
straightforward ONT protocols and automated sample analysis up to result reporting.
In addition, nanopore sequencing is compatible with any amplicon size, which is a clear
advantage over other existing sequencing technologies and also allows the processing
and resolution of mixed amplicon samples as demonstrated here. Finally, even when
the reference sequence database is incomplete or lacks closely related reference
sequences, we showed that the approach is robust and provides correct taxonomic
identification of the bacterial species.
Our approach has several limitations. (i) The taxonomic resolution is inherently
limited by the choice of a single-gene-based approach. Commonly used 16S rRNA gene
regions, for example, have been reported to allow for genus identification in 90% of
cases, for species identification in 65% to 83% of cases and to result in unsuccessful
identification in 1% to 14% of all analyzed isolates (8, 34, 35). Other approaches, such
as matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spec-
trometry may complementarily provide fast and reliable identification of clinically
relevant microorganisms (36). Yet, MALDI-TOF may also suffer from suboptimal iden-
tification due to limitations, including insufficient representation of reference species
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profiles in available commercial databases, absence of newly discovered species, and
the existence of several commercial systems (37–39). (ii) The dependency on database
quality and completeness in the LORCAN reference-based approach for consensus
building was explored extensively by using modified databases, which lacked reference
sequences closely related to the analyzed strains. Not surprisingly, consensus accuracy
was strongly affected, and LORCAN required reference databases of high quality and
completeness to reliably reach sequence qualities on par with the quality obtained by
the Sanger method. Even if databases contained sequences with up to 99% identity to
the analyzed species, further improvements could often be made by adding closer
reference sequences (Fig. 3). Importantly though for clinical diagnostics, taxonomic
identification based on the produced consensus sequence was far less affected by
database completeness. Even consensus sequences produced with distant reference
sequences (90% identity to the query sequence using an incomplete database)
allowed for reliable bacterial species identification when the generated consensus was
compared to a complete database. This finding indicates a high reliability of the
taxonomic identification despite the database dependency of the approach. This was
confirmed by extensive validation in our diagnostics department, which was based on
the parallel sequencing and analysis of clinical samples using both Sanger and nano-
pore sequencing over several months, which overall showed average sequence iden-
tities of 99.6% (and 99.8% for positive controls sequenced conjointly with the clinical
samples). (iii) Finally, the wet laboratory procedures still take several hours and would
need to be optimized to allow fast and efficient processing of several samples via
automation or via simplified steps.
In conclusion, we demonstrate that the combination of nanopore sequencing and
LORCAN pipeline offers a significant improvement over the well-established Sanger or
short-read sequencing approaches in terms of reliability (robustness against contami-
nated samples) and flexibility (read length limited by PCR only), while offering com-
parable turnaround time, cost, and reproducibility of the results. The described work-
flow has great potential to be successfully introduced in the routine of diagnostic
departments and may thus facilitate custom amplicon sequencing and further taxo-
nomic identification of bacterial pathogens.
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